EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2020). On theSindex it has a DataRank of 1.9. It has been cited 68 times, with 61 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.635
From this paper's citation signal
Citation Network Contribution
1.3
From 47 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 61 citers.
National Institutes of Health
Grant: R21DK105405
National Center for Advancing Translational Sciences
Grant: UL1TR000124
National Center for Advancing Translational Sciences
Grant: UL1TR001881
FWCI
4.96
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals